Biopharmaceuticals

Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results

prnewswire.com     Jul 29, 2008   2 related          

Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results BETHESDA, Md., July 29 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel,...                    

Living Cell Technologies: Living Cell Technologies Expands Its Management Team and Appoints Dr....

marketwire.com     Jul 29, 2008   8 related          

MELBOURNE, AUSTRALIA and AUCKLAND, NEW ZEALAND and BOULDER, CO (MARKET WIRE) Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today announced the expansion of its management team and the appointment of one of its...                    

Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008...

prnewswire.com     Jul 29, 2008   17 related          

Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008 SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- Cadence...                    

[29-07-2008] Grant Instruments unveils 3-in-1 heavy duty multi-functional orbital platform shaker

responsesource.com     Jul 29, 2008   3 related          

Heavy duty platform shaker provides orbital motion, reciprocation and vibration functions all in one powerful microprocessor controlled product, and builds on success of Grant-bio PS-M3D, the original multi-functional platform...                    

DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract...

webwire.com     Jul 28, 2008   1 related          

Leiden, The Netherlands/Parsippany, USA, June 2008 - DSM Biologics and Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) announced today that they have entered into an agreement with Avid Bio... [WebWire - Monday, July...                    

Innocoll Announces Dosing of First Patient in a Third US Phase 2 Clinical Trial to Investigate...

prnewswire.com     Jul 28, 2008   3 related          

Innocoll Announces Dosing of First Patient in a Third US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain ASHBURN, Va., July 28 /PRNewswire/ -- Innocoll,...                    

Perceptive Informatics Appoints Leading Imaging Expert Dr. Kenneth G. Faulkner to Vice President...

earthtimes.org     Jul 28, 2008   4 related          

BOSTON, July 28 -- Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services organization, announced today that it has appointed Kenneth...                    

EPIX Pharmaceuticals Announces Resignation of CEO; Names Elkan Gamzu Interim CEO

earthtimes.org     Jul 28, 2008   9 related          

LEXINGTON, Mass. - EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery...                    

Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development

prnewswire.com     Jul 28, 2008   2 related          

Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development Dr. Miller's Work Will Concentrate on the Continued Development of Insmed's Follow-On Biologics Product Portfolio RICHMOND, Va., July...                    

Watson Names Clare Carmichael Senior VP Human Resources

prnewswire.com     Jul 28, 2008   2 related          

CORONA, Calif., July 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced the appointment of Clare Carmichael as Senior Vice President, Human...